Hey there, intrepid Seeker! We’re The Kable, a curated Monday to Friday newsletter that delivers business intelligence to everyone in or on the periphery of the life sciences industry. We have a singular objective – to keep you informed about your industry. We read hundreds of articles from industry and mainstream media, blogs, and social feeds every day, to filter out the noise and bring you...
Pfizer’s new biotech baby; Novartis says 8000 bye-byes; Astella says hi to Sutro
P